Malaysia anticipates OEM growth from U.S. device clients

It's not just China and India that are emerging out of Asia as major medical device markets and industry players. Malaysia is yet another country in the region with a rapidly growing device distribution and manufacturing industry, pointing to another window of opportunity for global medical device giants seeking growth in emerging markets. But beyond that, Malaysia's The Star reports, many of the country's local device manufacturers and distributors expect major growth in original equipment manufacturing (OEM) demand from U.S. device clients, driven by double-digit growths in domestic device consumption and also surging business overseas. Companies such as Kuala Lumpur-based Dispo-Med, which makes devices focused on areas including respiratory care, anesthesiology and infusion therapy, now generate 95% of their revenue from the U.S. and Australia, according to the story. And they see OEM manufacturing for U.S. based companies as the way to keep revenue surging. Story

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.